WallStreetZenWallStreetZen

NASDAQ: PXMD
Paxmedica Inc Stock

$3.35-0.03 (-0.89%)
Updated Feb 6, 2023
PXMD Price
$3.35
Fair Value Price
N/A
Market Cap
$39.46M
52 Week Low
$1.36
52 Week High
$10.48
P/E
N/A
P/B
16.52x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
1.5
Operating Cash Flow
N/A
Beta
0.59
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

PXMD Overview

PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, and human african trypanosomiasis. It is also involved in developing PAX-102, an intranasal formulation of suramin for neurologic indications. The company was formerly known as Purinix Pharmaceuticals LLC and changed its name to PaxMedica, Inc. in April 2020. PaxMedica, Inc. was incorporated in 2018 and is based in Tarrytown, New York. PaxMedica, Inc. operates as a subsidiary of Tardimed Sciences LLC.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PXMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PXMD is poor value based on its book value relative to its share price (16.52x), compared to the US Biotechnology industry average (5.06x)
P/B vs Industry Valuation
PXMD's short-term assets ($5.98M) exceed its short-term liabilities ($3.59M)
Short-term Liabilities Financials
PXMD's short-term assets ($5.98M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more PXMD due diligence checks available for Premium users.

Be the first to know about important PXMD news, forecast changes, insider trades & much more!

PXMD News

Valuation

PXMD fair value

Fair Value of PXMD stock based on Discounted Cash Flow (DCF)
Price
$3.35
Fair Value
$2.99
Overvalued by
12.18%

PXMD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
16.52x
Industry
5.06x
PXMD is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PXMD's financial health

Profit margin

Revenue
$0.0
Net Income
-$11.5M
Profit Margin
0%

Assets to liabilities

Assets
$6.0M
Liabilities
$3.6M
Debt to equity
1.5
PXMD's short-term assets ($5.98M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PXMD's short-term assets ($5.98M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PXMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.6M
Investing
$0.0
Financing
$7.1M

PXMD vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
PXMD$39.46M-0.89%N/A16.52x
TARA$39.11M+3.00%-1.04x0.28x
AVRO$39.83M-2.15%-0.37x0.41x
NOVN$40.12M-1.20%-0.89x5.93x
FRLN$40.28M+7.83%-0.29x0.59x

Paxmedica Stock FAQ

What is Paxmedica's quote symbol?

NASDAQ: PXMD) Paxmedica trades on the NASDAQ under the ticker symbol PXMD. Paxmedica stock quotes can also be displayed as NASDAQ: PXMD.

If you're new to stock investing, here's how to buy Paxmedica stock.

What is the 52 week high and low for Paxmedica (NASDAQ: PXMD)?

(NASDAQ: PXMD) Paxmedica's 52-week high was $10.48, and its 52-week low was $1.36. It is currently -68.03% from its 52-week high and 146.32% from its 52-week low.

How much is Paxmedica's stock price per share?

(NASDAQ: PXMD) Paxmedica stock price per share is $3.35 today (as of Feb 6, 2023).

What is Paxmedica's Market Cap?

(NASDAQ: PXMD) Paxmedica's market cap is $39.46M, as of Feb 8, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Paxmedica's market cap is calculated by multiplying PXMD's current stock price of $3.35 by PXMD's total outstanding shares of 11,779,475.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.